720 related articles for article (PubMed ID: 19174795)
1. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome.
Langhorst J; Junge A; Rueffer A; Wehkamp J; Foell D; Michalsen A; Musial F; Dobos GJ
Am J Gastroenterol; 2009 Feb; 104(2):404-10. PubMed ID: 19174795
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
3. [Expression of human beta-defensin 2 and tumor necrosis factor-A in colonic mucosae of ulcerative colitis and diarrhea-predominant irritable bowel syndrome].
Li MR; Jiang K; Zhang QY
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):957-60. PubMed ID: 18756966
[TBL] [Abstract][Full Text] [Related]
4. Relationship between fecal lactoferrin and inflammatory bowel disease.
Dai J; Liu WZ; Zhao YP; Hu YB; Ge ZZ
Scand J Gastroenterol; 2007 Dec; 42(12):1440-4. PubMed ID: 17852860
[TBL] [Abstract][Full Text] [Related]
5. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease.
Foell D; Wittkowski H; Ren Z; Turton J; Pang G; Daebritz J; Ehrchen J; Heidemann J; Borody T; Roth J; Clancy R
J Pathol; 2008 Oct; 216(2):183-92. PubMed ID: 18729068
[TBL] [Abstract][Full Text] [Related]
6. Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice.
Annaházi A; Gecse K; Dabek M; Ait-Belgnaoui A; Rosztóczy A; Róka R; Molnár T; Theodorou V; Wittmann T; Bueno L; Eutamene H
Pain; 2009 Jul; 144(1-2):209-17. PubMed ID: 19450926
[TBL] [Abstract][Full Text] [Related]
7. [Significance of fecal lactoferrin in evaluation of disease activity in ulcerative colitis].
Xiang JY; Ouyang Q; Li GD
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2262-4. PubMed ID: 18001547
[TBL] [Abstract][Full Text] [Related]
8. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation.
Kane SV; Sandborn WJ; Rufo PA; Zholudev A; Boone J; Lyerly D; Camilleri M; Hanauer SB
Am J Gastroenterol; 2003 Jun; 98(6):1309-14. PubMed ID: 12818275
[TBL] [Abstract][Full Text] [Related]
9. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
Schoepfer AM; Beglinger C; Straumann A; Trummler M; Vavricka SR; Bruegger LE; Seibold F
Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of four fecal assays in the diagnosis of colitis.
Schoepfer AM; Trummler M; Seeholzer P; Criblez DH; Seibold F
Dis Colon Rectum; 2007 Oct; 50(10):1697-706. PubMed ID: 17762964
[TBL] [Abstract][Full Text] [Related]
11. Fecal beta-defensin-2 in children with inflammatory bowel diseases.
Kapel N; Benahmed N; Morali A; Svahn J; Canioni D; Goulet O; Ruemmele FM
J Pediatr Gastroenterol Nutr; 2009 Jan; 48(1):117-20. PubMed ID: 19172136
[TBL] [Abstract][Full Text] [Related]
12. Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins.
Sugi K; Saitoh O; Hirata I; Katsu K
Am J Gastroenterol; 1996 May; 91(5):927-34. PubMed ID: 8633583
[TBL] [Abstract][Full Text] [Related]
13. Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome.
Silberer H; Küppers B; Mickisch O; Baniewicz W; Drescher M; Traber L; Kempf A; Schmidt-Gayk H
Clin Lab; 2005; 51(3-4):117-26. PubMed ID: 15819166
[TBL] [Abstract][Full Text] [Related]
14. Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease.
Wehkamp J; Fellermann K; Herrlinger KR; Baxmann S; Schmidt K; Schwind B; Duchrow M; Wohlschläger C; Feller AC; Stange EF
Eur J Gastroenterol Hepatol; 2002 Jul; 14(7):745-52. PubMed ID: 12169983
[TBL] [Abstract][Full Text] [Related]
15. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.
Cremon C; Gargano L; Morselli-Labate AM; Santini D; Cogliandro RF; De Giorgio R; Stanghellini V; Corinaldesi R; Barbara G
Am J Gastroenterol; 2009 Feb; 104(2):392-400. PubMed ID: 19174797
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome.
Róka R; Rosztóczy A; Leveque M; Izbéki F; Nagy F; Molnár T; Lonovics J; Garcia-Villar R; Fioramonti J; Wittmann T; Bueno L
Clin Gastroenterol Hepatol; 2007 May; 5(5):550-5. PubMed ID: 17336590
[TBL] [Abstract][Full Text] [Related]
17. Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease.
Scarpa M; D'Incà R; Basso D; Ruffolo C; Polese L; Bertin E; Luise A; Frego M; Plebani M; Sturniolo GC; D'Amico DF; Angriman I
Dis Colon Rectum; 2007 Jun; 50(6):861-9. PubMed ID: 17473939
[TBL] [Abstract][Full Text] [Related]
18. Fecal calprotectin in first-degree relatives of patients with ulcerative colitis.
Montalto M; Curigliano V; Santoro L; Armuzzi A; Cammarota G; Covino M; Mentella MC; Ancarani F; Manna R; Gasbarrini A; Gasbarrini G
Am J Gastroenterol; 2007 Jan; 102(1):132-6. PubMed ID: 17100982
[TBL] [Abstract][Full Text] [Related]
19. Fecal Human β-Defensin 2 in Children with Cystic Fibrosis: Is There a Diminished Intestinal Innate Immune Response?
Ooi CY; Pang T; Leach ST; Katz T; Day AS; Jaffe A
Dig Dis Sci; 2015 Oct; 60(10):2946-52. PubMed ID: 26271615
[TBL] [Abstract][Full Text] [Related]
20. Role of fecal calprotectin in the diagnosis and treatment of segmental colitis associated with diverticulosis.
Tursi A; Elisei W; Giorgetti G; Aiello F; Brandimarte G
Minerva Gastroenterol Dietol; 2011 Sep; 57(3):247-55. PubMed ID: 21769075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
